Blogarama: The Oldest Blog Directory

Over the years, former CFO David Johnston has provided help for many firms, including financing assistance for biotech firms. Biotech has become a major part of the economy and is likely to… Read More

Despite weak markets, Avalon GloboCare (NASDAQ: ALBT) stock has been able to defend its valuation. Except for a late-day blip on Tuesday, ALBT shares have been consolidating at the $3.40 le… Read More

Algorics Inc., one of the fastest-growing biometrics and data science companies, expands its board of directors with another key appointment. The newest member to join the board, Mr. Amit… Read More

For episode 12, we catch up with Vijay Karwal, CFO of Affamed Therapeutics. Find out where there is still a preference for stories that are de risked from the perspective of being closer to… Read More

Editor’s Note: Today’s guest article comes from our friend Bryan Bottarelli over at Monument Traders Alliance. Bryan is my go-to source for day trading tips and tricks. He really… Read More

When it comes to tackling bodily viruses or parasites, it is quite a risky job. One little mistake and the previously efficient part can get damaged- temporarily or permanently. The Medical… Read More

For episode 15, we chat with Dr. Richard Sachse, Chief Medical Officer at SOTIO. Listen in to find out why early collaboration between clinical and research teams is essential for drug devel… Read More

ICER Weekly View View as Webpage Sign up for ICER's Weekly View Newsletter   Weekly View February 24, 2023 From the desk of Priya Ranade… Read More

Ils veulent tuer la mort… Read More

SINGAPORE, March 07, 2023 (GLOBE NEWSWIRE) — Novotech, the leading Asia Pacific centred biotech CRO will be at BIO Europe (March 20-22, 2023) to meet with clinical-stage biotechs a… Read More

The US Food and Drug Administration’s (FDA) Office of Tissues and Advanced Therapies (OTAT) held a recent town hall where three experts from the regulator provided guidance on how to d… Read More

For episode 22 we connect with Dr. Kristian Reich, Founder & Chief Scientific Officer of MoonLake Immunotherapeutics. Find out the key things that have contributed to Dr. Reich’s s… Read More

With Carlos Sanmarco One of our brightest new minds, Mitchell Pease, recently sat down with Carlos Sanmarco. Carlos is an expert in Drug Development and Clinical Research, with over 22 year… Read More

This episode features an interview with Manu Garg, VP, Head of Healthcare Consulting at Definitive Healthcare. Sarah and Manu discussed the transformative role of healthcare commercial intel… Read More

For episode 27, we sit down with Sean Bohen,  CEO of Olema Oncology. Stay tuned to learn what the future of personalized cancer treatment holds, and learn how Olema is helping to addres… Read More

Biotech has seen tremendous growth and innovation in the past few decades. With innovations in disease detection, precision medicine, and drug development, every breakthrough in biotech tech… Read More

Amy Del Medico, Vial’s VP of Ophthalmology, discusses her background and what brought her to the Vial team. Amy joined the Vial team in January 2023. To learn more about opportuni… Read More

For episode 29, we chat with Aneesh Chopra , President at CareJourney.  Stay tuned to hear from the United States first Chief Technology Officer about how the private and public sectors… Read More

For episode 30, we sit down with Craig Lipset, co-chair at the Decentralized Trials & Research Alliance.  Learn more about the future of decentralized trials and how the increasing… Read More

Le point éco - Mardi 25 avril 2023 Le point éco Mardi 25 avril 2023   Chère lectrice, cher lecteur, Le manque de main-d'œuvre en Sui… Read More

Le point éco - Mercredi 26 avril 2023 Le point éco Mercredi 26 avril 2023   Chère lectrice, cher lecteur, Comme dans le reste du monde, le… Read More

Following a series of recent statements, Gareth Soloway, a respected market analyst and the founder of inthemoneystocks.com, has issued a stark warning for investors. Soloway anticipates a l… Read More

Resilient Cities Catalyst appoints Christine Heenan and Dr. Carlos Martín Resilient Cities Catalyst – Christine Heenan, the Chief Communications Officer and Executive Partn… Read More

Clinical trials are essential for the development of new treatments for rare diseases, but they can be complex and challenging to execute. Patient input is a crucial component of rare diseas… Read More

How far has the psychedelics medicines industry come over the past 12 months? Well, it depends on where you look. If you look at the stock market, the view isn’t very good: the charts… Read More

You will be fascinated to know that Biotechs use fermentation and harness biocatalysts such as yeast, enzymes, etc. to become microscopic manufacturing plants, helping to fuel the world! Fr… Read More

For Episode 35, we sit down with Simon Allen, CEO of Anebulo Pharmaceuticals.  Find out how Anebulo is addressing the unmet need for treatment of acute cannabinoid intoxication and othe… Read More

Carlos Naranjo, Vial’s Director of Sales, discusses his background, what lead him to Vial, and his advice for startup biotech companies. Carlos joined the Vial team in April 2023… Read More

Advancements in neuroscience research and technology are paving the way for groundbreaking developments in the field of neurology. At the 2022 Precision Neuroscience Summit, scientists and i… Read More

The Changing Financial Landscape in Biotech Funding in the biotech industry has experienced significant volatility in recent years. Despite recent hardships in the industry, analysts are… Read More

Bet_Noire Acumen Prescription drugs (NASDAQ:ABOS), Institution Labs (NASDAQ:ESTA), Arcus Biosciences (NYSE:RCUS) and BridgeBio Pharma (NASDAQ:BBIO) are 4 of BTIG’s prime picks for sm… Read More

Signant Health, the leader in evidence generation for modern clinical trials, announced today the acquisition of DSG – a leading provider of electronic data capture (EDC) and direct da… Read More

Listen to what your heart says, and act on it. Sometimes it may be right or not, but most of the time it leads you to the right place. We, as humans, have changed the fortune of many industr… Read More

LA JOLLA, Calif.–(BUSINESS WIRE)–Vector Space Biosciences announces it has begun filing for licensing and registration for the design, development and launching of biological Cu… Read More

Explore oncology clinical trials with Rich McCormick, EVP of Clinical Strategy and VP of Oncology. Join us as he answers 5 pivotal questions, shedding light on the journey, strategies, chall… Read More

Following a period of bearish conditions, investors are anxiously awaiting the next big rally. A return to normal levels would help revitalize investor portfolios and confidence following a… Read More

First Wave BioPharma (NASDAQ: FWBI) is a company whose valuation disconnect is getting too big to ignore. In fact, several milestones reached are likely to turn into catalysts that could sen… Read More

Medically Trained AI for Insights Generation and Communication https://www.linkedin.com/in/thomas-hughes-66762a7b/Speaker: Tom HughesCEO, Virtual Science AIMedical Affairs Professi… Read More

Virtual biotechs have demonstrated that they can change drug discovery through increased efficiency and rapid Proof of Concept (PoC). In the past, biopharma companies mainly conducted resear… Read More

Biotech, pharmaceutical, and life sciences companies all hope AI will streamline drug development and make it more efficient, and 38% have already adopted the technology, according to Deloit… Read More

PowerPatent BioTechX First Draft answer for Patents USPTO PowerPatent Seminar Bao Tran presents at Boston International Discussion board 2-28-2023 Highly effective Concept PowerPate… Read More

When most companies go public, they are somewhat mature. They typically have earnings and cash flow. Tech company initial public offerings, or IPOs, are a bit different. These companies are… Read More

The Company’s AI Platform Predicts Efficacy and Safety of Clinical Trials to Optimize Trial Design, and Identify Key Response Populations TEL AVIV, Israel–(BUSINESS WIRE)&ndash… Read More

Does the convergence of tech and biology hold the key to reshaping biotech’s data infrastructure? Our recent chat with Alfredo Andere, co-founder and CEO at Latch Bio, certainly suppor… Read More

Healthcare companies are always on the lookout to improve outcomes in the healthcare system and consolidate the healthcare industry. Healthcare providers offer essential services and game-ch… Read More

What if your vision could be saved by the precise application of innovative biotech? Join us as we talk to David Esposito, President &  CEO of ONL Therapeutics, and delve deep into… Read More

What if your vision could be saved by the precise application of innovative biotech? Join us as we talk to David Esposito, President &  CEO of ONL Therapeutics, and delve deep into… Read More

Le point éco - Mardi 26 septembre 2023 Le point éco Mardi 26 septembre 2023   Chère lectrice, cher lecteur, Si le diable s'habille toujour… Read More

New York, NY — (SBWIRE) — 02/24/2022 — Gene therapy is a vital field and one generating a wealth of R&D jobs in pharma today. Companies such as Pfizer are keen to ca… Read More

‍Biotechnology, a rapidly evolving field, is transforming various sectors, from agriculture and medicine to environmental conservation and sports. This science has been instrumental in d… Read More

Biotechnology, a rapidly evolving field, is transforming various sectors, from agriculture and medicine to environmental conservation and sports. This science has been instrumental in develo… Read More

Elgan pharma scam or legit? Reviews and complaints Elgan Pharma presents itself as a late-stage biotech company with a focus on pioneering neonatal therapies. While the goal of improving car… Read More

European Union lawmakers are being urged to avoid too much risk aversion from holding back the potential of the homegrown biotech sector.Developments in biotech could be transformative in a… Read More

Biotech stocks, especially those that don’t have a medicine on the market yet, tend to be among the riskiest investments available. Even under the best of conditions, clinical tria… Read More

Avance Clinical Invited to Brief 45 Korean Biotechs on Their GlobalReady Drug Development Pathway from Korea and Australia to the US Read More

Der Pharmakonzern Roche investiert mehr als 7 Mrd. Dollar in das Magenmittel eines US-Biotechs. Die Therapie soll Patienten mit entzündlichen Darmerkrankungen helfen Read More